| Renal Impairment Pharmacokinetics (PK) Trial of Afabicin (NCT07758608) | Debiopharm International SA | 2026-08-01 |
| A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults (NCT07143448) | 35Pharma Inc | 2026-08-01 |
| Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease (NCT07708350) | Daniel Bauer | 2026-08-01 |
| Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO) (NCT07573436) | University of Utah | 2026-08-01 |
| Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC (NCT07698106) | University Health Network, Toronto | 2026-08-01 |
| Phase I Study of SM2275 Injection in Patients With Advanced Solid Tumors (NCT07750132) | Beijing StarMab Biomed Technology Ltd | 2026-08-01 |
| Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults (NCT04806347) | University of Wisconsin, Madison | 2026-08-01 |
| A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies (NCT07735533) | Umoja Biopharma | 2026-08-01 |
| Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis (NCT07281924) | University of Wisconsin, Madison | 2026-08-01 |
| Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T) (NCT07215416) | Timothy Yu | 2026-08-01 |
| A Clinical Study on the Safety and Efficacy of Wide-Band Ultrasound Combined With Traditional Chinese Medicine Preparations in the Prevention and Treatment of Keloids (NCT07679243) | Fujian Medical University Union Hospital | 2026-08-01 |
| Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS (NCT05602142) | Johns Hopkins University | 2026-08-01 |
| A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors (NCT07730190) | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 2026-08-01 |
| The Impact of Cobenfy Maintenance on Cocaine's Effects (NCT07624227) | Joshua A. Lile, Ph.D. | 2026-08-01 |
| Dose-Escalation Study of Artesunate Patients With IPF (NCT05988463) | Joseph C. Wu | 2026-08-01 |
| Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma (NCT07725406) | Weill Medical College of Cornell University | 2026-08-01 |
| A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis (NCT07765524) | Shenzhen Fosun Kairos Biotechnology Co., Ltd. | 2026-08-01 |
| Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants (NCT07744802) | Deciphera Pharmaceuticals, LLC | 2026-08-01 |
| Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer (NCT07637851) | ARCAGY/ GINECO GROUP | 2026-08-01 |
| RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal Neuralgia (NCT07596485) | Kriya Therapeutics, Inc. | 2026-08-01 |
| ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1 (NCT07472322) | University of Wisconsin, Madison | 2026-08-01 |
| A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations (NCT07647107) | PT Bio Farma | 2026-08-01 |
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors (NCT07753226) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-08-01 |
| Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer (NCT07675876) | Carcinex Inc | 2026-08-01 |
| A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD) (NCT07748403) | Prime Medicine, Inc. | 2026-08-01 |
| Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube (NCT07556484) | Mayo Clinic | 2026-08-01 |
| Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects (NCT07697443) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-08-01 |
| Nanopulse Laser Therapy (NCT07520383) | The University of Texas Medical Branch, Galveston | 2026-08-01 |
| Phase I Study of Single-Agent KGX105 in Patients With Advanced or Metastatic Solid Tumors (NCT07702955) | Kangabio AUSTRALIA LTD PTY | 2026-08-01 |
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes (NCT07712562) | Dren Bio | 2026-08-01 |
| SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL) (NCT07725705) | Institute of Hematology & Blood Diseases Hospital, China | 2026-08-01 |
| Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification (NCT07687004) | Institute of Hematology & Blood Diseases Hospital, China | 2026-08-01 |
| A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) (NCT07430202) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-08-01 |
| A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adults (NCT07717775) | Addpharma Inc. | 2026-08-01 |
| Tumor-Specific T-Cells (cCTL:GL01) for Advanced Gastrointestinal Cancer (NCT07735065) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2026-08-01 |
| Gene Therapy Trial for CLN6 Batten Disease (NCT07582484) | The Charlotte and Gwenyth Gray Foundation | 2026-08-01 |
| Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease (NCT07566494) | National Heart, Lung, and Blood Institute (NHLBI) | 2026-07-31 |
| A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery (NCT07676890) | West China Hospital | 2026-07-31 |
| Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid Cancer (NCT07703163) | West China Hospital | 2026-07-31 |
| A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery (NCT07724106) | West China Hospital | 2026-07-31 |
| A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma (NCT07472790) | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 2026-07-31 |
| Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males (NCT07604272) | Northwestern University | 2026-07-31 |
| Luvometinib in Combination With Serplulimab for NF2-Related Tumors (NCT07708285) | Beijing Tiantan Hospital | 2026-07-31 |
| In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma (NCT07715630) | Chongqing Precision Biotech Co., Ltd | 2026-07-31 |
| Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With Open Angle Glaucoma or Ocular Hypertension (NCT07641296) | SpyGlass Pharma, Inc. | 2026-07-31 |
| AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer (NCT07617337) | Chugai Pharmaceutical | 2026-07-31 |
| A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions (NCT07734064) | Astellas Institute for Regenerative Medicine | 2026-07-31 |
| A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants (NCT07737717) | ModernaTX, Inc. | 2026-07-31 |
| YMN-A02 for Advanced pMMR Colorectal Cancer With Liver Metastases (NCT07610707) | West China Hospital | 2026-07-30 |
| A Mass Balance Study of [14C]HS-10504 (NCT07764705) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-07-30 |
| Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype (NCT07341867) | Andrew Hantel, MD | 2026-07-30 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD) (NCT07719257) | Zhuhai United Laboratories Co., Ltd. | 2026-07-30 |
| Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain (NCT07035119) | Medical University of South Carolina | 2026-07-30 |
| U96-CAR-T-Cells For R/R B-ALL (NCT07511426) | The First Affiliated Hospital of Soochow University | 2026-07-30 |
| A Phase I/II Study of FG-M108 Plus FG-B901 in Advanced CLDN18.2-Positive Solid Tumors (NCT07704866) | FutureGen Biopharmaceutical (Beijing) Co., Ltd | 2026-07-30 |
| A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio (NCT07745439) | The Third Xiangya Hospital of Central South University | 2026-07-30 |
| Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease (NCT07346157) | Sabine Mueller, MD, PhD | 2026-07-30 |
| QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants (NCT07708272) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-07-30 |
| Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study (NCT07739485) | Liu Shu | 2026-07-30 |
| GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours (NCT07297667) | Canadian Cancer Trials Group | 2026-07-30 |
| A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer (NCT07711184) | Jiangsu HengRui Medicine Co., Ltd. | 2026-07-30 |
| Cannabis and Opioid Use Disorder, Study 2 (NCT07661446) | University of Kentucky | 2026-07-30 |
| YMN-A02 for Advanced Primary Hepatocellular Carcinoma. (NCT07580261) | West China Hospital | 2026-07-30 |
| A Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection in Participants With Moderate-to-Severe Non-Cancer Chronic Pain (NCT07751094) | The Third Xiangya Hospital of Central South University | 2026-07-30 |
| A Phase Ia/Ib Study of HW221043 in Participants With Advanced Solid Tumors (NCT07719920) | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 2026-07-30 |
| A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours (NCT07533708) | Shanghai Henlius Biotech | 2026-07-30 |
| Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer (NCT07707674) | Evopoint Biosciences Inc. | 2026-07-30 |
| Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants (NCT07685600) | AstraZeneca | 2026-07-30 |
| A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases (NCT07731685) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-07-30 |
| The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteers (NCT07719218) | Ruijin Hospital | 2026-07-30 |
| A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (NCT07749586) | Arvinas Inc. | 2026-07-29 |
| A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight (NCT07708493) | Boehringer Ingelheim | 2026-07-29 |
| A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B (NCT07730567) | Addpharma Inc. | 2026-07-29 |
| A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007) (NCT07677163) | Merck Sharp & Dohme LLC | 2026-07-29 |
| Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study (NCT07739511) | Liu Shu | 2026-07-29 |
| A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body (NCT07722585) | Bayer | 2026-07-28 |
| A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants (NCT07736638) | AbbVie | 2026-07-28 |
| Optimizing PreTerm Infant Ampicillin Dosing (NCT07610486) | Duke University | 2026-07-28 |
| PSTB100 Study in Healthy Adult Subjects (NCT07702279) | Prospect Therapeutics (Nanjing) Limited | 2026-07-28 |
| Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults (NCT07638800) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-07-28 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity (NCT07731139) | Pfizer | 2026-07-28 |
| A Study of MI226 Injection for Abdominal Fat Accumulation (NCT07749742) | Nanjing Minova Pharmaceutical Co., Ltd. | 2026-07-28 |
| A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults With Multifocal Motor Neuropathy (NCT07610564) | argenx | 2026-07-27 |
| Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT) (NCT07601425) | Atavistik Bio, Inc | 2026-07-27 |
| Ketoconazole Effects on the Daily Cortisol Rhythm in Mild Autonomous Cortisol Secretion (NCT07649317) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-07-27 |
| A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants (NCT07723833) | AstraZeneca | 2026-07-27 |
| Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies (NCT07565220) | Sawa Ito, MD | 2026-07-27 |
| A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile (NCT07649096) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-07-27 |
| 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients (NCT07509229) | Sheba Medical Center | 2026-07-26 |
| Neonatal White Matter Injury Trial (WRAP) (NCT07688746) | Bridget LaMonica Ostrem, M.D., Ph.D. | 2026-07-26 |
| TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors (NCT07713732) | Treeline Biosciences, Inc. | 2026-07-25 |
| MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia (NCT07492771) | MicrobiotiX Co., Ltd | 2026-07-25 |
| Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis (NCT07249840) | Brigham and Women's Hospital | 2026-07-24 |
| A Study to Evaluate the Safety, Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects (NCT07717749) | Addpharma Inc. | 2026-07-24 |
| A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults (NCT07731100) | Pfizer | 2026-07-24 |
| An Open-Label PET/CT Imaging Study to Evaluate Brain Serotonin Transporter (SERT) Occupancy Following Single-Dose Administration of LG-0317 Tablets in Healthy Participants (NCT07708428) | LinGang Laboratory | 2026-07-24 |
| Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants (NCT07512427) | OPKO Health, Inc. | 2026-07-24 |
| Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2) (NCT07493577) | Dr David Hasan, M.D. | 2026-07-23 |
| REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension (NCT07675824) | Regeneron Pharmaceuticals | 2026-07-23 |
| A Clinical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma (NCT07661537) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-07-23 |